-+ 0.00%
-+ 0.00%
-+ 0.00%
Vittia invests R$ 4.7 million to expand inoculant production capacity
Share
Listen to the news
Vittia invests R$ 4.7 million to expand inoculant production capacity
  • Vittia invested R$ 4.7 million in inoculant plant expansion in the first nine months of 2026, adding 1,920,000 doses of monthly capacity.
  • A further R$ 3.3 million funded installation of a new filling cell for formulated products at its biological products plant.
  • Total capital expenditure reached R$ 22.6 million, down 8% from the same period a year earlier.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vittia SA published the original content used to generate this news brief on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending